Clinical Trial Update: Active Comparator-Controlled Study to Assess Safety and Efficacy of ISIS-FXIRx in Total Knee Arthroplasty [Phase 2]

View source ↗

Summary

Phase 2 active-comparator trial evaluated the safety and efficacy of ISIS-FXIRx for preventing venous thromboembolism after total knee arthroplasty; the study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• ISIS-FXIRx (IONIS-FXIRx)

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Venous Thromboembolism | Phase 2 | Status: COMPLETED